HIGHLIGHTS
- What: The findings of this analysis, which indicated an increase in antibacterial potency due to synergism, are presented in Table-2. The authors introduced two novel USAMPs, WW-185 and WOW and investigated their combined antibacterial efficacy. The study showed that the combination of WW-185 and WOW exhibited minimal hemolytic activity, indicating a favorable safety profile.
- Who: Ali H. Salama from the Department of Pharmacy, Faculty of Pharmacy, Middle East University, Amman, Jordan have published the paper: Combined action of two synthetic ultrashort antimicrobial peptides exhibiting synergistic effects against clinically significant resistant bacteria, in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.